Glikla 80 Tablet
Marketer
Dr. Patro's Research Laboratories (OPC) Pvt Ltd
Salt Composition
Gliclazide (80mg)
Overview Glikla 80 Tablet
Diabetase 80mg tablets are indicated for adult patients with type 2 diabetes. A sulfonylurea, it regulates blood glucose, mitigating the risk of diabetic complications like vision impairment and nephropathy. Diabetase 80mg may be used independently or in conjunction with other therapies and should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted. Continuous use is vital; premature discontinuation, without medical consultation, risks elevated blood sugar and subsequent complications, including neuropathy and limb loss. This medication forms one component of a comprehensive treatment plan encompassing dietary adjustments, physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include gastrointestinal distress and hypoglycemia (low blood sugar). Learn to recognize hypoglycemia symptoms (e.g., sweating, vertigo, tremor) and appropriate management strategies. Regular meals and readily available glucose sources (like juice or sweets) are crucial. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Weight gain is a possible side effect. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior to commencing treatment, inform your physician of any pre-existing conditions such as cardiovascular disease, thyroid disorders, or endocrine imbalances. Its suitability during pregnancy or lactation requires medical assessment. Regular blood glucose monitoring and periodic blood tests (to evaluate blood cell counts and liver function) are recommended.
Uses of Glikla 80 Tablet
Managing type 2 diabetes
Major Benefits of Glikla 80 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glikla 80 Tablet with a meal.
Common Side effects of Glikla 80 Tablet:
- Hypoglycemia (low blood glucose level)
- Weight gain
- Flatulence
- Diarrhea
- Headache
- Nausea
- Dizziness
How to use Glikla 80 Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glikla 80 Tablet with a meal.
How Glikla 80 Tablet works:
This drug treats diabetes by stimulating pancreatic insulin secretion, thereby reducing blood glucose.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glikla 80 Tablet and alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Glikla 80 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Lactation and Glikla 80 Tablet are incompatible. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Impaired driving is possible with both hypo- and hyperglycemia. Refrain from driving if such symptoms arise.
KidneySAFE IF PRESCRIBED
Glikla 80 Tablet poses no safety concerns for individuals with kidney impairment and does not require dosage modification. Nevertheless, its use is prohibited in patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with severe hepatic impairment should use Glikla 80 Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Glikla 80 Tablet :
Should you forget a Glikla 80 Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing schedule. Never take a double dose.
Facts to Know About Glikla 80 Tablet
| Label | Value |
|---|---|
| Chemical Category | Second-generation sulfonylurea |
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
| Action Class | Insulin-Stimulating Sulfonylureas |



